Absence of Nosocomial Transmission of Imported Lassa Fever During Use of Standard Barrier Nursing Methods

Overview

Journal Emerg Infect Dis

Specialty Infectious Diseases

Date 2018 May 19

PMID 29775178

Citations 3

Authors

Anna Grahn

Andreas Brave

Thomas Tolfvenstam

Marie Studahl

Affiliations

Soon will be listed here.

Abstract

Nosocomial transmission of Lassa virus (LASV) is reported to be low when care for the index patient includes proper barrier nursing methods. We investigated whether asymptomatic LASV infection occurred in healthcare workers who used standard barrier nursing methods during the first 15 days of caring for a patient with Lassa fever in Sweden. Of 76 persons who were defined as having been potentially exposed to LASV, 53 provided blood samples for detection of LASV IgG. These persons also responded to a detailed questionnaire to evaluate exposure to different body fluids from the index patient. LASV-specific IgG was not detected in any of the 53 persons. Five of 53 persons had not been using proper barrier nursing methods. Our results strengthen the argument for a low risk of secondary transmission of LASV in humans when standard barrier nursing methods are used and the patient has only mild symptoms.

Citing Articles

Seroprevalence of anti-Lassa Virus IgG antibodies in three districts of Sierra Leone: A cross-sectional, population-based study.

Grant D, Engel E, Roberts Yerkes N, Kanneh L, Koninga J, Gbakie M PLoS Negl Trop Dis. 2023; 17(2):e0010938.

PMID: 36758101 PMC: 9946222. DOI: 10.1371/journal.pntd.0010938.

Methanol Fixation, but not Giemsa Staining, Inactivates Ebola and Lassa Viruses in Peripheral Blood Smears Made on Plastic Microscope Slides.

Relich R, Feldmann H, Haddock E Am J Trop Med Hyg. 2020; 103(5):2085-2090.

PMID: 32959767 PMC: 7646817. DOI: 10.4269/ajtmh.19-0840.

Diagnostics for Lassa fever virus: a genetically diverse pathogen found in low-resource settings.

Mazzola L, Kelly-Cirino C BMJ Glob Health. 2019; 4(Suppl 2):e001116.

PMID: 30899575 PMC: 6407561. DOI: 10.1136/bmjgh-2018-001116.

References

McCormick J, King I, WEBB P, Johnson K, OSullivan R, Smith E . A case-control study of the clinical diagnosis and course of Lassa fever. J Infect Dis. 1987; 155(3):445-55. DOI: 10.1093/infdis/155.3.445. View

Zweighaft R, Fraser D, Hattwick M, Winkler W, Jordan W, Alter M . Lassa fever: response to an imported case. N Engl J Med. 1977; 297(15):803-7. DOI: 10.1056/NEJM197710132971504. View

Kakuda T . Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity. Clin Ther. 2000; 22(6):685-708. DOI: 10.1016/S0149-2918(00)90004-3. View

McCormick J, WEBB P, Krebs J, Johnson K, Smith E . A prospective study of the epidemiology and ecology of Lassa fever. J Infect Dis. 1987; 155(3):437-44. DOI: 10.1093/infdis/155.3.437. View

Johnson K, McCormick J, WEBB P, Smith E, ELLIOTT L, King I . Clinical virology of Lassa fever in hospitalized patients. J Infect Dis. 1987; 155(3):456-64. DOI: 10.1093/infdis/155.3.456. View

Bannister B . Viral haemorrhagic fevers imported into non-endemic countries: risk assessment and management. Br Med Bull. 2010; 95:193-225. DOI: 10.1093/bmb/ldq022. View

Crowcroft N . Management of Lassa fever in European countries. Euro Surveill. 2003; 7(3):50-2. DOI: 10.2807/esm.07.03.00337-en. View

Grahn A, Brave A, Lagging M, Dotevall L, Ekqvist D, Hammarstrom H . Imported Case of Lassa Fever in Sweden With Encephalopathy and Sensorineural Hearing Deficit. Open Forum Infect Dis. 2016; 3(4):ofw198. PMC: 5152670. DOI: 10.1093/ofid/ofw198. View

Cooper C, Gransden W, Webster M, King M, OMahony M, Young S . A case of Lassa fever: experience at St Thomas's Hospital. Br Med J (Clin Res Ed). 1982; 285(6347):1003-5. PMC: 1500309. DOI: 10.1136/bmj.285.6347.1003. View

10.

Helmick C, WEBB P, Scribner C, Krebs J, McCormick J . No evidence for increased risk of Lassa fever infection in hospital staff. Lancet. 1986; 2(8517):1202-5. DOI: 10.1016/s0140-6736(86)92206-3. View

11.

Ehlkes L, George M, Samosny G, Burckhardt F, Vogt M, Bent S . Management of a Lassa fever outbreak, Rhineland-Palatinate, Germany, 2016. Euro Surveill. 2017; 22(39). PMC: 5709955. DOI: 10.2807/1560-7917.ES.2017.22.39.16-00728. View

12.

Frame J, Hanson A . Endemic Lassa fever in Liberia. V. Distribution of Lassa virus activity in Liberia: hospital staff surveys. Trans R Soc Trop Med Hyg. 1984; 78(6):761-3. DOI: 10.1016/0035-9203(84)90012-9. View

13.

Amorosa V, MacNeil A, McConnell R, Patel A, Dillon K, Hamilton K . Imported Lassa fever, Pennsylvania, USA, 2010. Emerg Infect Dis. 2010; 16(10):1598-600. PMC: 3294406. View

14.

Frame J, Hanson A . Endemic Lassa fever in Liberia. VI. Village serological surveys for evidence of Lassa virus activity in Lofa County, Liberia. Trans R Soc Trop Med Hyg. 1984; 78(6):764-70. DOI: 10.1016/0035-9203(84)90013-0. View

15.

Lehmann C, Kochanek M, Abdulla D, Becker S, Boll B, Bunte A . Control measures following a case of imported Lassa fever from Togo, North Rhine Westphalia, Germany, 2016. Euro Surveill. 2017; 22(39). PMC: 5709954. DOI: 10.2807/1560-7917.ES.2017.22.39.17-00088. View

16.

McCormick J, King I, WEBB P, Scribner C, Craven R, Johnson K . Lassa fever. Effective therapy with ribavirin. N Engl J Med. 1986; 314(1):20-6. DOI: 10.1056/NEJM198601023140104. View

17.

Fisher-Hoch S, Price M, Craven R, Price F, Forthall D, Sasso D . Safe intensive-care management of a severe case of Lassa fever with simple barrier nursing techniques. Lancet. 1985; 2(8466):1227-9. DOI: 10.1016/s0140-6736(85)90752-4. View

18.

Kitching A, Addiman S, Cathcart S, Bischop L, Krahe D, Nicholas M . A fatal case of Lassa fever in London, January 2009. Euro Surveill. 2009; 14(6). View

19.

Raabe V, Kann G, Ribner B, Morales A, Varkey J, Mehta A . Favipiravir and Ribavirin Treatment of Epidemiologically Linked Cases of Lassa Fever. Clin Infect Dis. 2017; 65(5):855-859. PMC: 5682919. DOI: 10.1093/cid/cix406. View

20.

Holmes G, McCormick J, Trock S, CHASE R, Lewis S, Mason C . Lassa fever in the United States. Investigation of a case and new guidelines for management. N Engl J Med. 1990; 323(16):1120-3. DOI: 10.1056/NEJM199010183231607. View